Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-10-03

Clinical Trial Update: Beneficial Effects of Lactobacillus Reuteri DSM 17938 Supplementation on Asthmatic Children [NA]

View source ↗

Summary

A completed clinical trial reports beneficial effects of Lactobacillus reuteri DSM 17938 supplementation in asthmatic children.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus reuteri DSM 17938 (Lactobacillus reuteri DSM 17938)

Snippet

Sponsor: Federico II University | Conditions: Airways Allergic Inflammation of Asthmatic Children | NA | Status: COMPLETED